|
RAB5C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.437900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.600800E-03 |
| Normal-vs-Stage2 |
6.694000E-02 |
| Normal-vs-Stage3 |
8.806700E-04 |
| Normal-vs-Stage4 |
4.062800E-03 |
| Stage1-vs-Stage2 |
9.517400E-01 |
| Stage1-vs-Stage3 |
1.841220E-01 |
| Stage1-vs-Stage4 |
4.226800E-01 |
| Stage2-vs-Stage3 |
3.176800E-01 |
| Stage2-vs-Stage4 |
4.753200E-01 |
| Stage3-vs-Stage4 |
8.424400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.557400E-04 |
| Normal-vs-AfricanAmerican |
2.873200E-01 |
| Normal-vs-Asian |
2.781600E-01 |
| Caucasian-vs-AfricanAmerican |
2.977400E-01 |
| Caucasian-vs-Asian |
2.429200E-01 |
| AfricanAmerican-vs-Asian |
9.140000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.79880000000488E-05 |
| Normal-vs-Female |
4.876300E-03 |
| Male-vs-Female |
6.227600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.444480E-02 |
| Normal-vs-Age(41-60Yrs) |
3.196800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.592500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.374400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.695400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.703960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.571800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.070400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.192400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.905400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.439400E-01 |
| Classical-VS-Follicular |
2.570600E-01 |
| Classical-VS-Other |
1.239820E-01 |
| Classical-VS-Normal |
8.882100E-03 |
| Tall-VS-Follicular |
8.964000E-01 |
| Tall-VS-Other |
2.670200E-01 |
| Tall-VS-Normal |
1.248260E-02 |
| Follicular-VS-Other |
4.160800E-01 |
| Follicular-VS-Normal |
5.000600E-03 |
| Other-VS-Normal |
7.981100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.576400E-03 |
| Normal-vs-N1 |
2.299500E-03 |
| N0-vs-N1 |
1.832220E-01 |
|
|
